These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 29188574

  • 21. Protocol for hit-to-lead optimization of compounds by auto in silico ligand directing evolution (AILDE) approach.
    Mei L, Wu F, Hao G, Yang G.
    STAR Protoc; 2021 Mar 19; 2(1):100312. PubMed ID: 33554146
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T, Lenselink B, Pala D, McRobb F, Repasky M, Sherman W.
    Methods Mol Biol; 2015 Mar 19; 1335():251-76. PubMed ID: 26260606
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
    Lee Y, Lazim R, Macalino SJY, Choi S.
    Curr Opin Struct Biol; 2019 Apr 19; 55():147-153. PubMed ID: 31102980
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT, Mohammad T, Hasan GM, Hassan MI.
    Curr Top Med Chem; 2018 Apr 19; 18(20):1755-1768. PubMed ID: 30360721
    [Abstract] [Full Text] [Related]

  • 30. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M, Kooistra AJ, Ritschel T, Leurs R, de Esch IJ, de Graaf C.
    Curr Opin Pharmacol; 2016 Oct 19; 30():59-68. PubMed ID: 27479316
    [Abstract] [Full Text] [Related]

  • 31. Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.
    Rosano C, Ponassi M, Santolla MF, Pisano A, Felli L, Vivacqua A, Maggiolini M, Lappano R.
    AAPS J; 2016 Jan 19; 18(1):41-6. PubMed ID: 26573009
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S.
    Methods Mol Biol; 2018 Jan 19; 1705():1-21. PubMed ID: 29188556
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Modeling G protein-coupled receptors and their interactions with ligands.
    Costanzi S.
    Curr Opin Struct Biol; 2013 Apr 19; 23(2):185-90. PubMed ID: 23415855
    [Abstract] [Full Text] [Related]

  • 36. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L, Guan M, Jin H, Liu Z, Zhang L.
    Chem Biol Drug Des; 2015 Dec 19; 86(6):1438-50. PubMed ID: 26072970
    [Abstract] [Full Text] [Related]

  • 37. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
    Ciancetta A, Jacobson KA.
    Methods Mol Biol; 2018 Dec 19; 1705():45-72. PubMed ID: 29188558
    [Abstract] [Full Text] [Related]

  • 38. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y, Schneider G.
    Nat Rev Drug Discov; 2008 Aug 19; 7(8):667-77. PubMed ID: 18636071
    [Abstract] [Full Text] [Related]

  • 39. Challenges and Opportunities in Drug Discovery of Biased Ligands.
    Rodríguez-Espigares I, Kaczor AA, Stepniewski TM, Selent J.
    Methods Mol Biol; 2018 Aug 19; 1705():321-334. PubMed ID: 29188569
    [Abstract] [Full Text] [Related]

  • 40. Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures.
    Rodríguez D, Ranganathan A, Carlsson J.
    Curr Top Med Chem; 2015 Aug 19; 15(24):2484-503. PubMed ID: 26126906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.